STOCK TITAN

Mednow to Host Quarterly Conference Call on Tuesday November 29, 2022, at 8:30am EST on its Fourth-Quarter 2022 Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

TORONTO--(BUSINESS WIRE)-- Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company will be hosting its quarterly conference call on Tuesday November 29, 2022 at 8:30am EST. The conference call will cover its fourth-quarter 2022 financial results.

During the call, the Mednow team will provide an update on Mednow’s expansion, recent strategic partnerships, milestones, M&A activities, and fourth-quarter 2022 financial results. Please use one of the two dial-in numbers provided below five minutes before the scheduled start time and specify the Mednow call.

Conference Call details:
Canada/USA Toll-free: 1-800-319-4610
International Toll: 1-604-638-5340

Reported results will be available on the Company’s website at: https://investors.mednow.ca/financial-reports/

About Mednow Inc.

Mednow (TSXV: MNOW) (OTCQX:MDNWF) is a healthcare technology company offering virtual access with a high-standard of care. Designed with accessibility and quality of care in mind, Mednow provides virtual pharmacy and telemedicine services as well as doctor home visits through an interdisciplinary approach to healthcare that is focused on the patient experience. Mednow’s services include free at-home medication delivery, virtual consultations with clinicians, a user-friendly interface to easily fill, transfer, and refill prescriptions, access to healthcare professionals through an intuitive chat experience and the specialized PillSmart™ system that packages prescriptions in easy to use daily dose packs, each labelled with the date and time of the next dose.

To learn more, follow Mednow on Facebook, Twitter, LinkedIn, and Instagram, or visit our website at www.mednow.ca/.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Investor Relations:

Benjamin Ferdinand, Chief Financial Officer

ir@mednow.ca

1.855.686.6300

Source: Mednow Inc.

Mednow Inc

OTC:MDNWF

MDNWF Rankings

MDNWF Latest News

MDNWF Stock Data

Pharmacies and Drug Stores
Retail Trade
Packaged Software